Drug intelligence / Profile preview

parbendazole

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Parbendazole is a benzimidazole anthelmintic primarily utilized in veterinary medicine for the control of gastrointestinal nematodes in livestock such as sheep, cattle, and swine. Its primary mechanism of action involves high-affinity binding to the colchicine-sensitive site of beta-tubulin, which inhibits microtubule polymerization and disrupts essential cellular functions, including glucose uptake and waste excretion in parasites. Beyond its veterinary applications, parbendazole is frequently employed as a research tool in cell biology to study cytoskeletal dynamics and phenotypic profiling. It has been explored in preclinical studies for potential repositioning as an anti-cancer agent due to its ability to induce mitotic arrest and apoptosis in mammalian cells by interfering with microtubule assembly.

Brand names
HelmatacWorm Guard
Other names
Methyl (5-butyl-1H-benzimidazol-2-yl)carbamatePAB
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on parbendazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on parbendazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call